1. Defining disease modifying therapy for Alzheimer's disease;Cummings;J. Prev. Alzheimers Dis.,2017
2. (2023). Highlights of prescribing information: Leqembi (lecanemab-irmb). Eisai Inc. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/761269s000lbl.pdf
3. (2022). Highlights of prescribing information: Aduhelm (aducanumab-avwa). Biogen. https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/761178s005lbl.pdf
4. CSF markers for incipient Alzheimer's disease;Blennow;Lancet Neurol.,2003
5. Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B;Klunk;Ann. Neurol.,2004